NCT01585506View on ClinicalTrials.gov

Psychosocial Factors Related to Compliance With Treatment With Biphasic Insulin Analogues

CompletedOBSERVATIONAL
Enrollment

3,618

Participants

Timeline

Start Date

September 20, 2010

Primary Completion Date

December 20, 2010

Study Completion Date

December 20, 2010

Conditions
DiabetesDiabetes Mellitus, Type 2
Interventions
OTHER

No treatment given

"Patients to complete the WHO-5 Well-being Index questionnaire"

OTHER

No treatment given

"Physicians to complete two questionnaires, Demographic Data and Disease and Treatment Course and Questionnaire of Potential Difficulties in the Period of Treatment Switching from Insulin to Its Analogues"

Trial Locations (1)

PL-02-274

Novo Nordisk Investigational Site, Warsaw

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY

NCT01585506 - Psychosocial Factors Related to Compliance With Treatment With Biphasic Insulin Analogues | Biotech Hunter | Biotech Hunter